Skip to main content

Table 4 Adjusted odds ratio for death and/or default outcomes among HIV-infected TB patients.

From: Viral hepatitis and HIV-associated tuberculosis: Risk factors and TB treatment outcomes in Thailand

1. Those with cure, complete, death outcomes

Comparison groups versus non-reactive

All patients

Culture-confirmed TB

 

n

AOR

95% CI

n

AOR

95% CI

   

L

U

  

L

U

HBsAg +

385

1.0

0.3

3.3

188

0.5

0.1

4.9

Anti-HCV +

504

1.1

0.6

1.9

253

1.4

0.6

3.6

HBsAg and anti-HCV +

374

2.1

0.6

7.6

185

4.8

0.5

42.9

2. Those with cure, complete, death, and default outcomes

Comparison groups versus non-reactive

All patients

Culture-confirmed TB

 

n

AOR

95% CI

n

AOR

95% CI

   

L

U

  

L

U

HBsAg +

420

2.7

1.1

6.4

207

5.5

1.4

21.9

Anti-HCV +

549

1.2

0.8

2.0

281

2.0

1.0

4.0

HBsAg and anti-HCV +

401

1.4

0.4

4.7

198

1.7

0.3

11.2

  1. + sign indicates reactive; bold type indicates statistical significance (p < 0.05); TB, tuberculosis, HIV, human immunodeficiency virus; AOR, adjusted odds ratio; CI, confidence interval; L, lower bound; U, upper bound; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus, N, number of patients included in the model.
  2. *Adjusted odds ratios from multivariate logistic regression analyses adjusted for TB disease severity, HIV disease severity, co-trimoxazole use, fluconazole use, anti-retroviral use, whether or not received directly observed therapy, hospitalized at enrollment and been treated for TB previously